0O27 Stock Chart & Stats
€8.12
-€0.14(-1.99%)
At close: 4:00 PM EST
€8.12
-€0.14(-1.99%)
Day’s Range― - ―
52-Week Range€6.70 - €10.30
Previous CloseN/A
Volume1.10K
Average Volume (3M)689.00
Market Cap
€47.65M
Enterprise Value€91.45
Total Cash (Recent Filing)€7.04M
Total Debt (Recent Filing)€48.01M
Price to Earnings (P/E)―
Beta0.79
Next Earnings
Aug 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.59
Shares Outstanding6,062,930
10 Day Avg. Volume2,033
30 Day Avg. Volume689
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)0.65
Price to Sales (P/S)0.53
P/FCF Ratio15.82
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.2
Revenue Forecast (FY)€93.60M
Bulls Say, Bears Say
Bulls Say
Recurring Aftermarket RevenueHönle's business model includes replacement lamps, consumables and servicing tied to installed systems. That installed-base driven recurring revenue smooths demand volatility, supports cash conversion and provides a stable high-margin revenue stream over multi-year equipment lifecycles.
Positive Free Cash FlowThe shift to sustained positive operating and free cash flow versus prior years demonstrates improving internal funding capacity. Durable FCF reduces reliance on external financing, allows reinvestment in R&D or service expansion, and gives the company time to translate operational fixes into profit.
Manageable LeverageA debt-to-equity near 0.63 and broadly stable leverage provide financial flexibility to fund product development and service growth. With meaningful equity, the company can absorb modest shocks and pursue incremental investments without immediate restructuring, supporting medium-term strategic moves.
Bears Say
Multi-year Revenue DeclineSustained revenue decline erodes scale and limits operating leverage. Over time, shrinking top-line hinders fixed-cost absorption, reduces R&D and service investment capacity, and risks weakening the installed base growth that underpins recurring aftermarket sales.
Persistent UnprofitabilityOngoing negative net and EBIT margins limit retained earnings and constrain capital allocation. Durable profitability shortfalls impair the firm's ability to finance growth, depress returns on equity (TTM ROE ~-4.7%), and make the business more vulnerable to cyclical downturns without structural margin improvement.
Limited Deleveraging CapacityAlthough cash flow is positive, its current scale covers only a small portion of debt, limiting rapid deleveraging. That constrained coverage reduces headroom for larger capex or acquisitions and leaves the company exposed if cash generation dips before profitability and cash flow further improve.
Dr. Hoenle AG News
0O27 FAQ
What was Dr. Hoenle AG’s price range in the past 12 months?
Dr. Hoenle AG lowest share price was €6.70 and its highest was €10.30 in the past 12 months.
What is Dr. Hoenle AG’s market cap?
Dr. Hoenle AG’s market cap is €47.65M.
When is Dr. Hoenle AG’s upcoming earnings report date?
Dr. Hoenle AG’s upcoming earnings report date is Aug 18, 2026 which is in 7 days.
How were Dr. Hoenle AG’s earnings last quarter?
Dr. Hoenle AG released its earnings results on May 19, 2026. The company reported €0.11 earnings per share for the quarter, the consensus estimate of €0.11 by €0.
Is Dr. Hoenle AG overvalued?
According to Wall Street analysts Dr. Hoenle AG’s price is currently Overvalued.
Does Dr. Hoenle AG pay dividends?
Dr. Hoenle AG pays a Annually dividend of €0.2 which represents an annual dividend yield of N/A. See more information on Dr. Hoenle AG dividends here
What is Dr. Hoenle AG’s EPS estimate?
Dr. Hoenle AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dr. Hoenle AG have?
Dr. Hoenle AG has 6,062,930 shares outstanding.
What happened to Dr. Hoenle AG’s price movement after its last earnings report?
Dr. Hoenle AG reported an EPS of €0.11 in its last earnings report, expectations of €0.11. Following the earnings report the stock price went down -1.86%.
Which hedge fund is a major shareholder of Dr. Hoenle AG?
Currently, no hedge funds are holding shares in GB:0O27
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Dr. Hoenle AG Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-5.78%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-5.37%
Trailing 12-Months
Company Description
Dr. Hoenle AG
Dr. Hönle AG is a global provider specializing in industrial ultraviolet (UV) technologies and related systems, with operations spanning Germany and international markets. The company organizes its business into three main segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives division develops industrial bonding solutions for critical applications within sectors such as consumer electronics, medical technology, optics and opto-electronics, the automotive industry, and glass processing. Its Equipment & Systems segment focuses on developing solutions for the efficient drying of inks and coatings, the precise curing of adhesives and plastics, comprehensive surface disinfection, and advanced solar simulation. Lastly, the Glass & Lamps division manufactures quartz glass tubing and rods, which are vital for the lamp, automotive, semiconductor, and fiber optic cable industries, alongside producing specialized lamps utilized for water purification and the drying of various coatings and adhesives. Founded in 1976, Dr. Hönle AG is headquartered in Munich, Germany.
Technical Analysis
LPKF Laser & Electronics
―
Manz AG
―
MAX Automation
―
Singulus Technologies
―
Suss Microtec
―